Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
63.9M
-
Shares change
-
+885K
-
Total reported value, excl. options
-
$1.51B
-
Value change
-
+$17.3M
-
Put/Call ratio
-
0.24
-
Number of buys
-
104
-
Number of sells
-
-87
-
Price
-
$23.56
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q2 2025
225 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q2 2025.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.9M shares
of 64.3M outstanding shares and own 99.33% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (6.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.48M shares), BlackRock, Inc. (4.17M shares), Kynam Capital Management, LP (3.43M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (3.35M shares), Vestal Point Capital, LP (3.1M shares), VANGUARD GROUP INC (3M shares), FMR LLC (2.91M shares), Sofinnova Investments, Inc. (2.79M shares), and Woodline Partners LP (2.61M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.